Related Experiment Video
Updated: Sep 17, 2025

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Linking obstructive sleep apnea with pulmonary hypertension via pooled prevalence and causal association: A
Dongru Du1, Jiangyue Qin2, Xueru Hu3
1Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, PR China; State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, 610041, PR China.
Background:
The coexisting prevalence and causal associations between obstructive sleep apnea (OSA) and pulmonary hypertension (PH) warranted further investigations.
Objectives:
To investigate the prevalence of PH in patients with OSA and OSA in patients with PH and reveal the bidirectional causal association between OSA and PH via Mendelian randomization (MR).
Methods:
Eligible records were selected from PubMed, Web of Science and Scopus. The pooled prevalence of PH in OSA patients and OSA in PH patients, as well as the clinical characteristics of patients with PH-OSA overlap were evaluated. MR data were obtained from the Integrative Epidemiology Unit and the Finngen cohort. The inverse variance weighted mode was applied as the main approach in the MR analysis. MR‒Egger regression, leave-one-out analysis and the Cochrane Q test were also conducted.
Results:
Thirteen studies with 1792 participants were included. The pooled prevalence of PH in OSA and OSA in PH reached 36 % and 34 %, respectively. Patients with OSA-PH overlap were associated with a lower FEV1/FVC (%) compared with OSA patients without PH, and were associated with male sex, older age (year), greater body mass index (kg/m2) and greater apnea‒hypopnea index (n/h) compared with PH patients without OSA. The MR suggested that OSA has a causal effect on PH, whereas PH has no causal effect on OSA.
Conclusion:
OSA and PH are highly prevalent mutual comorbidities. OSA appears to be causally linked to PH. However, further prospective and mechanistic studies are required to confirm this directionality and determine the clinical impact.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Sleep Apnea
The condition is more prevalent among...
Other Pulmonary Disorders
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pulmonary Embolism I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

